Aller au contenu principal
Profil bibliographique

Fei Li

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

102Publications signalées
3595Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesChromatin Remodeling and CancerMechanisms of cancer metastasisCAR-T cell therapy research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Peptide Angio‐3 Attenuates Pulmonary Fibrosis Via Modulation of the Coagulation Factor Xa—Protease‐Activated Receptor‐1 Signaling Axis

Dan Wang, Fei Li, Huiling Chen, Bochuan Deng et autres

Pulmonary fibrosis (PF) is a chronic, progressive, and often fatal interstitial lung disease characterized by interstitial remodeling, fibroblastic foci formation, and excessive extracellular matrix (ECM) deposition. Current therapeutic options remain limited and are associated with unfavorable prognoses. Growing evidence indicates that dysregulated …

cn (code pays fourni par la source)

0 citations The FASEB Journal
2025 article OpenAlex

Genistein resists castration-resistant prostate cancer by inhibiting the androgen receptor pathway

Xiaoping Yu, Lujie Zheng, Jiali Yan, Yan Luo et autres

Prostate cancer is a prevalent malignancy, often diagnosed at advanced stages and associated with poor prognosis. Genistein, a soybean isoflavone, has demonstrated antitumor effects against castration-resistant prostate cancer in vivo. Our results indicate that genistein effectively downregulates the expression of key enzymes …

cn (code pays fourni par la source)

2 citations Journal of Asian Natural Products Research
Accès ouvert 2024 article OpenAlex

NLRP10 maintains epidermal homeostasis by promoting keratinocyte survival and P63-dependent differentiation and barrier function

Yeonhee Cho, Zhongzheng Cao, Xin Luo, Jennifer J. Tian et autres

Atopic dermatitis (AD) is a common chronic inflammatory skin disorder characterized by disrupted epidermal barrier function and aberrant immune responses. Despite recent developments in new therapeutics for AD, there is still a large unmet medical need for disease management due to the …

us (code pays fourni par la source)

9 citations Cell Death and Disease
Accès ouvert 2024 article OpenAlex

Structural and mechanistic insights into a lysosomal membrane enzyme HGSNAT involved in Sanfilippo syndrome

Boyang Zhao, Zhongzheng Cao, Yi Zheng, Phuong Trang Nguyen et autres

Heparan sulfate (HS) is degraded in lysosome by a series of glycosidases. Before the glycosidases can act, the terminal glucosamine of HS must be acetylated by the integral lysosomal membrane enzyme heparan-α-glucosaminide N-acetyltransferase (HGSNAT). Mutations of HGSNAT cause HS accumulation and consequently …

us (code pays fourni par la source)

8 citations Nature Communications
Accès ouvert 2024 article OpenAlex

Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE

Keshu Zhou, Tingyu Wang, Ling Pan, Wei Xu et autres

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has different epidemiology in Chinese vs. Western patients, but there are few studies of CLL/SLL in large populations of Chinese patients. ALPINE is a global phase 3 trial investigating Bruton tyrosine kinase inhibitors zanubrutinib vs. ibrutinib …

cn (code pays fourni par la source)

8 citations Annals of Hematology
2024 conference-abstract OpenAlex

Abstract 6348: Unveiling diverse trimeric forms of STEAP1 in human prostate cancer cells: Exploring STEAP1-STEAP2 interdependence for expression and plasma membrane localization

Cong Li, Lingming Liang, Joonhee Park, Olga Pryshchep et autres

Abstract Six-Transmembrane Epithelial Antigen of the Prostate 1 (STEAP1) is an emerging therapeutic target that is a member of the STEAP1-4 family of metalloreductases. We recently reported the preclinical characterization of xaluritamig (AMG 509), a STEAP1 XmAb® 2+1 T-cell engager molecule that …

us (code pays fourni par la source)

1 citation Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.